SINGAPORE, March 18, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or...
SINGAPORE, March 04, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or...
SINGAPORE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or...
CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology PR...
CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update PR...
CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor...
Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology PR Newswire SINGAPORE, Sept...
CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo...
Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell...
A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has...
CytoMed Therapeutics to Ring Nasdaq Closing Bell PR Newswire SINGAPORE, May 11, 2023 SINGAPORE, May 11, 2023...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.